AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 APR 1 - (NewsRx.com & NewsRx.net) -- Positron emission tomography (PET) and PET/computed tomography (CT) provide better detection of malignant lymph nodes, recurrent cancers, and aid in radiotherapy planning.
According to recent research published in the International Journal of Gynecological Cancer, "The advent of PET and PET/CT now enables us to detect metabolically active gynecologic cancers with greater accuracy than was possible with anatomic imaging.
"Fluorine-18 fluorodeoxyglucose PET has been useful in differentiation of malignant from benign lymph nodes, and residual or recurrent cancers from post-treatment changes. PET/CT produces additional information for the diagnosis and tissue biopsy as well as radiotherapy planning," wrote E.E. Kim and colleagues, University of Texas, M.D. Anderson Cancer Center.
The researchers concluded: "This paper reviews the principle and clinical utility of PET and PET/CT in the diagnosis, staging, ...